The use of porphyrins and non-ionizing radiation for treatment of cancer

被引：15

作者：

Evensen, JF

机构：

[1] Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospita, Oslo

来源：

ACTA ONCOLOGICA | 1995年 / 34卷 / 08期

关键词：

D O I：

10.3109/02841869509127237

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Photodynamic therapy (PDT) is the treatment of malignant lesions with visible light following systemic or local administration of a photosensitizer or its precursor. Initially, hematoporphyrin derivative and a purified component called Photofrin II was used for clinical PDT. Later on interest has focused on new sensitizers with more favourable absorption as regards light transmission in tissues. Twenty years of clinical experience has revealed that PDT is best applied to early stage cancers. The present review discusses the basic components of PDT and its clinical use in treatment of cancer.

引用

页码：1103 / 1110

页数：8

共 79 条

[1]

AGARWAL ML, 1991, CANCER RES, V51, P5993

[2]

AULER H., 1942, Z. Krebsforsck, V53, P65, DOI 10.1007/BF01792783

[3] PHOTORADIATION THERAPY OF ENDOBRONCHIAL LUNG CANCERS EMPLOYING THE PHOTODYNAMIC-ACTION OF HEMATOPORPHYRIN DERIVATIVE [J].